Skip to main content
OpenTrials

Clinical trial condition

Myelodysplastic-Myeloproliferative Diseases

Explore clinical trials studying Myelodysplastic-Myeloproliferative Diseases. Study availability and eligibility vary by location and protocol.

384 public trials 62 recruiting studies
Refine in advanced search Browse all conditions

Myelodysplastic-Myeloproliferative Diseases trial results

Completed

Randomized Study of ON 01910.Na in Refractory Myelodysplastic Syndrome Patients With Excess Blasts

NCT01241500

Conditions
Anemia, Anemia, Refractory, Anemia, Refractory, with Excess of Blasts, +17 more
Locations
  • Virginia G. Piper Cancer Center Scottsdale, Arizona, United States
  • University of California San Diego Moores Cancer Center La Jolla, California, United States
  • Stanford Cancer Center Stanford, California, United States
  • Yale Cancer Center New Haven, Connecticut, United States
View all 87 locations
View Trial Details
Completed

Efficacy and Safety of IV Rigosertib in MDS Patients With Excess Blasts Progressing After Azacitidine or Decitabine

NCT01928537

Conditions
Anemia, Anemia, Refractory, Anemia, Refractory, with Excess of Blasts, +17 more
Locations
  • Stanford University Cancer Center Stanford, California, United States
  • Rush University Medical Center Chicago, Illinois, United States
  • University of Chicago Medicine Chicago, Illinois, United States
  • University of Kansas Cancer Center and Medical Pavilion Westwood, Kansas, United States
View all 35 locations
View Trial Details
Completed

Treatment for Chronic Pain in Patients With Advanced Cancer

NCT00003687

Conditions
Amyloidosis, Blast Crisis, Blood Coagulation Disorders, +93 more
Locations
  • Cross Cancer Institute Edmonton, Alberta, Canada
  • Newfoundland Cancer Treatment and Research Foundation St. John's, Newfoundland and Labrador, Canada
  • Princess Margaret Hospital Toronto, Ontario, Canada
  • McGill University Montreal, Quebec, Canada
View Trial Details
Completed

Fludarabine Phosphate and Total Body Irradiation Followed by a Donor Peripheral Stem Cell Transplant in Treating Patients With Myelodysplastic Syndromes or Myeloproliferative Disorders

NCT00397813

Conditions
Anemia, Anemia, Hemolytic, Anemia, Refractory, +40 more
Locations
  • LDS Hospital Salt Lake City, Utah, United States
  • Veterans Administration Center-Seattle Seattle, Washington, United States
  • Fred Hutch/University of Washington Cancer Consortium Seattle, Washington, United States
View Trial Details

Related conditions